Johnson & Johnson
Joyce Lee is the Chief Information Officer (CIO), Pharmaceuticals. Joyce also serves on the Pharmaceuticals Group Operating Committee (GOC).
Previously, Joyce served as Vice President and CIO of VF Corporation, Asia Pacific. During her tenure, Joyce was a key member of two Senior VF Asia Executive Leadership teams, where she oversaw Information Technology (IT) strategy for VF Commercial brands and Global Product Supply. Joyce played a strategic role in leading and developing retail excellence and digital eCommerce technology innovation through collaborations with China digital titans including Alibaba and Tencent. She also successfully led the regional technology separation of a complex business spin-off initiative.
Prior to her role with VF corporation, Joyce was the Vice President and CIO of the Americas region for Janssen Pharmaceuticals. In this role, Joyce was a strategic member of the Janssen Americas Leadership Team and focused on IT strategy and developing and leading teams. Joyce worked in close collaboration with key pharmaceutical business stakeholders to drive transformation and value creation using innovative technology capabilities such as next generation digital patient access and support solutions. She modernized Medical Affairs and Medical Information capabilities, and enhanced customer engagement, data insight-driven and predictive solutions using advanced analytics to improve patient adherence and outcomes.
In addition to being a strategic technology leader, Joyce has proven business management capabilities and direct Profit & Loss experience. In an earlier role as Managing Director, Johnson & Johnson Consumer, Malaysia and Singapore, she led a diverse range of Johnson & Johnson Consumer personal care, healthcare and over-the-counter brands. Some of her key achievements included three years of consecutive double-digit top- and bottom-line growth and successful implementation of a new go-to-market sales business model.
This person is not in any offices
Johnson & Johnson
535 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.